Karen Yiqin Fan
PEOPLE

Karen Yiqin Fan

Partner
fan.karen.yiqin@dorsey.com
Shanghai P (86-21) 6135-6145 F (86-21) 6288-3222 New York P +1 (212) 415-9238 F +1 (646) 607-5576

Overview

Karen specializes in providing cutting-edge solutions for complex legal issues that arise from business globalization. With a wealth of experience advising clients on strategic planning for expanding businesses into the international market, Karen is well-versed in navigating the ever-changing legal and regulatory landscape.

Prior to joining Dorsey, Karen served as the North American Senior Legal Director at Fosun International (00656.HK), where she advised the board and executives on M&A transactions in the North American region. With private practice experience in Shanghai, Washington D.C., and New York, Karen has extensive experience in handling a full spectrum of corporate transactions, including:

  • cross-border M&A,
  • PE & VC investments,
  • international joint ventures, and
  • business sales and divestiture.
As an outside general counsel to international clients, Karen is skilled in teaming up with litigators and other specialists to prevent, detect, and resolve legal threats, such as corporate or commercial dispute resolution, post-closing risk control and compliance programs, internal investigations, executive transition, and government enforcement, under multicultural contexts. Karen's expertise and experience make her an invaluable asset to many organizations looking to expand into the international market.

Education & Admissions

New York University School of Law (LL.M., 2011)

East China University of Political Science and Law (LL.B., 2007),

  • Scholarship for Distinguished Student of Top 1%
  • Graduation thesis with honor

Admissions

  • New York
  • China (currently inactive)

Languages

  • English, Mandarin Chinese, Shanghai Dialect

Experience

Representative Experience

Cross-border M&A and PE/VC transactions, including:

  • Represented The Coca-Cola Company (NYSE: KO) in the sale of its bottling businesses for still beverages in Mainland China to Swire Group and China Oil and Foodstuffs Corporation
  • Represented R&F Properties (SEHK: 2777) in the sale of certain properties located at Guangzhou International Airport R&F Integrated Logistic Park valued at approximately US$1.0 billion to The Blackstone Group Inc.
  • Represented YA Healthway, a portfolio company of Qiangjiang YongAn Pharmaceutical (SHE: 002365), in the sale of a matrix of tangible and intangible assets to Jamieson Wellness (TSX: JWEL)
  • Represented Ballard Power Systems (TSX: BLDP) in the greenfield investment project at the Jiading Hydrogen Port, one of China’s leading automotive industry clusters, to establish a membrane electrode assembly (MEA) manufacturing facility and R&D center in Shanghai, China with a total investment amount of US$130 million
  • Represented Cainiao, as the U.S. counsel, in the acquisition of De Well, a provider of cross-border logistics solutions
  • Represented Eddingpharm in the acquisition of Eli Lily’s Rights in China for Ceclor® and Vancocin® as well as its Ceclor Manufacturing Facility in Suzhou
  • Represented Janchor Partners in the equity investment in Everest Medicine’s series C-2 led by Janchor Partners and completed by raising funds of US$ 310 million
  • Represented Fosun Health and Flagler Investment in the acquisition of a portfolio of essential healthcare properties located in four different cities in the U.S.
  • Represented multiple international investors in series B, B+ and C rounds of fundraising of a California-based biomedical company
  • Advised a leading Chinese investment conglomerate in its equity investment in a U.S.-based greenfield project running a cryptocurrency custodial platform
  • Advised a HKSE-listed public company in its intended acquisition of a billion-dollar hospitality resort in the Caribbean area*
  • Advised a Chinese private equity fund in its intended pre-IPO round equity investment in a market-dominating Fintech company in India*
  • Advised a Chinese private company in its acquisition of an Europe-based football club*
  • Advised a Chinese private company in its strategic investment in an art dealer business in Israel*

Effectively preventing, detecting and resolving legal or regulatory risks arising from the process of business globalization, including:

  • Provided advice to Chinese producers on various international trade issues, including the UFLPA sanctions, AD/CVD duties, and U.S. customs regulations
  • Advised a private equity fund on CFIUS issues in each cross-border transaction
  • Advised a Chinese lithium battery material producer in navigating the process of national security review in North America
  • Advised a Chinese energy company on responding to post-closing RFIs from CFIUS
  • Provided guidance to a biotech startup in the U.S. on CFIUS and export control issues related to its series-A round of fundraising from Asian investors
  • Advised a Chinese academic professional on actions against academic journal publishers in the UK and Europe to protect the client’s privacy rights under the GDPR
  • Assisted a cross-border service provider in establishing a global data and privacy protection protocol covering jurisdictions of the U.S., UK, Germany, Australia and China and managed local data counsels from various jurisdictions
  • Provided guidance to multiple cross-border service providers in navigating law enforcement actions undertaken by U.S. federal agencies, including the Department of Homeland Securities, Customs and Border Protection, Department of Justice, Department of Agriculture and etc.
  • Advised a Chinese bond-holder on strategies for negotiation with a U.S.-listed company, the bond-issuer, regarding debt restructuring
  • Provided guidance to a creditor on litigation and arbitration strategies in the U.S. and in Hong Kong regarding a cross-border financing arrangement
  • Conducted an internal investigation of an education organization to prevent sexual harassment allegations in China
  • Assisted a Chinese buyer in restructuring the executive team of an acquired target company post-closing

*matter handled prior to joining the firm

News & Resources

Articles

“Foreign Entity of Concern” and Its Impact under the Inflation Reduction Act
Trends in Chinese M&A
China Issues Rules on Foreign Investment Security Review to Stay in Line with International Practice
地缘政治日益复杂:如何应对“一带一路”国家的OFAC制裁风险?
China Forex Liberalization Unlocks Massive M&A Opportunities for Foreign Invested Enterprises
Update on China’s Recent Liberalization of the Legal Regime for Foreign Investment
How to Handle a #MeToo Moment: Legal, Language and Cultural Tips
United States to impose third set of Section 301 tariffs on $200 billion of Chinese-made products
How to Handle a #MeToo Moment: Legal, Language and Cultural Tips
中美贸易战阴影下 — 中国企业如何跨境应对美国知识产权侵权诉讼
德汇成功推动特拉华州立新规—非美国企业也能妥妥享受“客户-律师保密特权”

News & Press Mentions

IFLR1000 Ranks 13 Dorsey Lawyers and 13 Practices for 2023
Dorsey’s Shanghai Office Moves to CITIC Square 德汇上海分所搬迁至中信泰富广场
IFLR1000 2023 APAC Ranks Dorsey Lawyers and Practices 德汇律师和业务领域上榜IFLR1000 2023年度亚太地区排名
Karen Yiqin Fan Wins China Business Law Journal 2023 Rising Stars Award
Dorsey Wins China Business Law Journal 2022 Cross-Border Deal of the Year Award
Dorsey Wins China Business Law Journal Deals of the Year 2021
Dorsey’s China Practices and Attorneys Receive Multiple Legal Awards and Rankings
德汇中国业务及律师近期荣获多个法律奖项和排名
Dorsey Awarded Coveted Associate Membership by Shanghai Bar Association
Dorsey & Whitney Names New Partners
德汇代表亿腾医药就其收购礼来旗下两款著名抗生素产品希刻劳®和稳可信®以及位于苏州的希刻劳生产工厂提供全面法律服务
Dorsey Represents Eddingpharm in Acquisition of Eli Lilly’s Rights in China for Ceclor® and Vancocin® as well as its Ceclor Manufacturing Facility in Suzhou
Dorsey Adds Cross-Border Deals Veteran Karen Fan

Select Presentations

  • “Legal Challenges and Strategic Opportunities for Chinese Companies in Cross-border Transactions,” SelectUSA China Webinar on Green & Sustainable Development in Food and Beverage., U.S. Commercial Service, December 16, 2021.
  • Moderator of the panel “Doing Business in China,” “New China Business Landscape for American Companies,” co-hosted by AmCham Shanghai and the Washington State China Relations Council (WSCRC), December 10, 2021.

Industries & Practices

Cybersecurity, Privacy & Social Media
Government Solutions & Investigations
Healthcare Transactions & Regulations
International Arbitration & Litigation
  • Asia-Pacific
  • Banking & Financial Institutions
  • Capital Markets
  • China
  • Closely Held Businesses
  • Corporate Governance & Compliance
  • Creative Industries
  • Cybersecurity, Privacy & Social Media
  • Emerging Companies
  • Energy & Natural Resources
  • FinTech
  • Food, Beverage & Agribusiness
  • Government Solutions & Investigations
  • Healthcare & Life Sciences
  • Healthcare Transactions & Regulations
  • International Arbitration & Litigation
  • International Trade
  • Mergers & Acquisitions
  • National Security Law
  • Private Equity
  • Real Estate & Land Use
  • Technology
  • Technology Commerce

Professional & Civic

Professional Achievements

  • Judge to 2012 Jessup International Moot Competition
  • UNEP Environmental Envoy, 2005

Accolades

   Rising Stars 2023
  • Named one of Rising Stars 2023: Young elite lawyers in China’s legal market (international law firms), China Business Law Journal
  • Named a Rising Star Partner: M&A – Foreign: China, IFLR1000 2023 APAC Rankings
Karen Yiqin Fan